Athira Pharma (ATHA) Stock Chart & Stock Price History $0.30 -0.01 (-2.26%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$0.31 +0.00 (+1.32%) As of 06/20/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Athira Pharma Stock Price Performance The Athira Pharma (ATHA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 87.05%, with a year-to-date return of -48.36%. In the past month, the stock has increased 12.01%, reflecting recent market activity. As of the latest close, Athira Pharma traded at $0.30 with a market cap of $11.83 million and volume of 293,306 shares. Receive ATHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-5.87%1 Month Performance+12.01%3 Month Performance-8.76%Year-To-Date Performance-48.36%1 Year Performance-87.05% ATHA Stock Chart for Sunday, June, 22, 2025 ATHA Chart by TradingView Athira Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$0.31$0.30-2.26%$0.31$0.29293,306 shs$11.83 million06/19/2025$0.31$0.31$0.33$0.31125,198 shs$12.10 million06/18/2025$0.32$0.31-3.70%$0.33$0.31125,198 shs$12.10 million06/17/2025$0.32$0.32+0.47%$0.34$0.31188,542 shs$12.57 million06/16/2025$0.30$0.32+5.39%$0.35$0.31171,498 shs$12.51 million06/13/2025$0.31$0.30-1.78%$0.33$0.30138,462 shs$11.87 million06/12/2025$0.32$0.31-3.64%$0.34$0.31248,900 shs$12.08 million06/11/2025$0.34$0.32-6.76%$0.34$0.32181,377 shs$12.54 million06/10/2025$0.33$0.34+4.08%$0.35$0.32172,025 shs$13.45 million06/09/2025$0.36$0.33-8.06%$0.36$0.33368,223 shs$12.92 million Get the Latest News and Ratings for ATHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025$0.34$0.36+5.51%$0.37$0.34394,834 shs$14.06 million06/05/2025$0.33$0.34+3.39%$0.35$0.31576,716 shs$13.32 million06/04/2025$0.30$0.33+9.16%$0.34$0.31766,487 shs$12.88 million06/03/2025$0.29$0.30+6.03%$0.33$0.2713.78 million shs$11.80 million06/02/2025$0.30$0.29-5.50%$0.31$0.27705,642 shs$11.13 million05/30/2025$0.28$0.30+6.72%$0.32$0.286.23 million shs$11.78 million05/29/2025$0.29$0.28-1.81%$0.29$0.27970,386 shs$11.04 million05/28/2025$0.29$0.29+0.31%$0.29$0.27207,786 shs$11.24 million05/27/2025$0.28$0.29+3.99%$0.30$0.26206,460 shs$11.21 million05/26/2025$0.28$0.28$0.29$0.2651,839 shs$10.78 million05/23/2025$0.27$0.28+2.03%$0.29$0.2651,839 shs$10.78 million05/22/2025$0.27$0.27+0.74%$0.27$0.2631,641 shs$10.56 million05/21/2025$0.27$0.27+0.15%$0.28$0.2763,865 shs$10.48 million Related Companies IPSC Stock Chart KLRS Stock Chart AVTX Stock Chart ALGS Stock Chart ARTV Stock Chart PEPG Stock Chart BLUE Stock Chart AADI Stock Chart RNXT Stock Chart STTK Stock Chart Receive ATHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATHA) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersWhy hasn't Elon tweeted about this?Behind the scenes, there's an entirely different Tesla story brewing… . It's about a quiet stream of income...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athira Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athira Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
